Two Sigma Advisers’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19,560
| Closed | -$210K | – | 2440 |
|
|
2025
Q1 | $210K | Buy |
19,560
+4,240
| +28% | +$45.6K | ﹤0.01% | 2118 |
|
|
2024
Q4 | $196K | Buy |
15,320
+9,035
| +144% | +$116K | ﹤0.01% | 2130 |
|
|
2024
Q3 | $173K | Sell |
6,285
-880
| -12% | -$24.3K | ﹤0.01% | 2104 |
|
|
2024
Q2 | $208K | Buy |
7,165
+1,810
| +34% | +$52.5K | ﹤0.01% | 2201 |
|
|
2024
Q1 | $239K | Buy |
5,355
+4,585
| +595% | +$204K | ﹤0.01% | 2153 |
|
|
2023
Q4 | $29.9K | Buy |
+770
| New | +$29.9K | ﹤0.01% | 2431 |
|
|
2023
Q2 | – | Sell |
-3,680
| Closed | -$174K | – | 2548 |
|
|
2023
Q1 | $174K | Buy |
3,680
+3,150
| +594% | +$149K | ﹤0.01% | 2292 |
|
|
2022
Q4 | $36.8K | Buy |
+530
| New | +$36.8K | ﹤0.01% | 2386 |
|